Eventide Asset Management, LLC Biocryst Pharmaceuticals Inc Transaction History

Eventide Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$6.96 - $8.81 $6.04 Million - $7.64 Million	867,111 Added 78.62%	1,970,000 $13.9 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $8.76 Million - $13.1 Million	1,102,889 New	1,102,889 $9.2 Million
Q1 2019 May 15, 2019	SELL	$7.38 - $9.72 $7.73 Million - $10.2 Million	-1,047,000 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$5.52 - $7.99 $5.78 Million - $8.37 Million	1,047,000 New	1,047,000 $7.99 Million
Q1 2018 May 15, 2018	SELL	$4.35 - $5.82 $1.26 Million - $1.69 Million	-290,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$4.1 - $5.97 $1.19 Million - $1.73 Million	290,000	290,000 $1.52 Million

279

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Eventide Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Eventide Asset Management, LLC with notifications on news.